Similar articles for PMID: 21118657

Year	Number of Results
1995	2
1998	1
2000	1
2002	1
2003	4
2004	1
2005	2
2006	3
2007	1
2008	2
2009	2
2010	1
2011	6
2012	3
2013	4
2014	7
2015	8
2016	13
2017	11
2018	19
2019	15
2020	8
2021	3
2022	2

1

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.

Dean O, Giorlando F, Berk M. Dean O, et al. J Psychiatry Neurosci. 2011 Mar;36(2):78-86. doi: 10.1503/jpn.100057. J Psychiatry Neurosci. 2011. PMID: 21118657 Free PMC article. Review.

2

N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.

Minarini A, Ferrari S, Galletti M, Giambalvo N, Perrone D, Rioli G, Galeazzi GM. Minarini A, et al. Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):279-292. doi: 10.1080/17425255.2017.1251580. Epub 2016 Nov 2. Expert Opin Drug Metab Toxicol. 2017. PMID: 27766914 Review.

3

The promise of N-acetylcysteine in neuropsychiatry.

Berk M, Malhi GS, Gray LJ, Dean OM. Berk M, et al. Trends Pharmacol Sci. 2013 Mar;34(3):167-77. doi: 10.1016/j.tips.2013.01.001. Epub 2013 Jan 29. Trends Pharmacol Sci. 2013. PMID: 23369637 Review.

4

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R. Deepmala, et al. Neurosci Biobehav Rev. 2015 Aug;55:294-321. doi: 10.1016/j.neubiorev.2015.04.015. Epub 2015 May 6. Neurosci Biobehav Rev. 2015. PMID: 25957927 Free article. Review.

5

N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.

Bavarsad Shahripour R, Harrigan MR, Alexandrov AV. Bavarsad Shahripour R, et al. Brain Behav. 2014 Mar;4(2):108-22. doi: 10.1002/brb3.208. Epub 2014 Jan 13. Brain Behav. 2014. PMID: 24683506 Free PMC article. Review.

6

N-acetylcysteine as a new prominent approach for treating psychiatric disorders.

Smaga I, Frankowska M, Filip M. Smaga I, et al. Br J Pharmacol. 2021 Jul;178(13):2569-2594. doi: 10.1111/bph.15456. Epub 2021 May 5. Br J Pharmacol. 2021. PMID: 33760228 Review.

7

Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review.

Yolland COB, Phillipou A, Castle DJ, Neill E, Hughes ME, Galletly C, Smith ZM, Francis PS, Dean OM, Sarris J, Siskind D, Harris AWF, Rossell SL. Yolland COB, et al. Nutr Neurosci. 2020 Feb;23(2):139-148. doi: 10.1080/1028415X.2018.1478766. Epub 2018 May 30. Nutr Neurosci. 2020. PMID: 29847303 Review.

8

N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence.

Ooi SL, Green R, Pak SC. Ooi SL, et al. Biomed Res Int. 2018 Oct 22;2018:2469486. doi: 10.1155/2018/2469486. eCollection 2018. Biomed Res Int. 2018. PMID: 30426004 Free PMC article.

9

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis.

Cotton SM, Berk M, Watson A, Wood S, Allott K, Bartholomeusz CF, Bortolasci CC, Walder K, O'Donoghue B, Dean OM, Chanen A, Amminger GP, McGorry PD, Burnside A, Uren J, Ratheesh A, Dodd S. Cotton SM, et al. Trials. 2019 Nov 28;20(1):658. doi: 10.1186/s13063-019-3786-5. Trials. 2019. PMID: 31779696 Free PMC article.

10

[Effectiveness of N-acetylcysteine in the treatment of schizophrenia].

Miyake N, Miyamoto S. Miyake N, et al. Nihon Shinkei Seishin Yakurigaku Zasshi. 2016 Apr;36(2):29-35. Nihon Shinkei Seishin Yakurigaku Zasshi. 2016. PMID: 27333656 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed